Canada markets closed

RepliCel Life Sciences Inc. (RP.V)

TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
0.12500.0000 (0.00%)
At close: 11:18AM EST
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2021-12-31
2020-12-31
2019-12-31
Total Revenue
353.735
353.735
353.735
252.609
Operating Expenses
Research Development
635.964
1,149
819.403
2,196
Selling General and Administrative
1,200
1,506
884.704
1,074
Total Operating Expenses
1,834
2,652
1,682
3,270
Operating Income or Loss
-1,480
-2,298
-1,328
-3,018
Interest Expense
10.426
5.528
176.085
141.427
Total Other Income/Expenses Net
-2,356
-1,769
-252.376
64.109
Income Before Tax
-3,847
-4,073
-1,580
-2,954
Income from Continuing Operations
-3,847
-4,073
-1,580
-2,954
Net Income
-3,847
-4,073
-1,580
-2,954
Net Income available to common shareholders
-3,847
-4,073
-1,580
-2,954
Basic EPS
-
-0.13
-0.06
-0.12
Diluted EPS
-
-0.13
-0.06
-0.12
Basic Average Shares
-
32,487
26,961
24,107
Diluted Average Shares
-
32,487
26,961
24,107
EBITDA
-
-4,067
-1,327
-3,016